Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (5): 86-94.doi: 10.6040/j.issn.1671-7554.0.2024.0658
• Clinical Medicine • Previous Articles
HUANG Xin, WANG Mengxue, FU Shufan, ZHANG Qiyue, XU Li
CLC Number:
| [1] Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer[J]. Gastroenterology, 2020, 159(1): 335-349. [2] Fock KM. Review article: the epidemiology and prevention of gastric cancer[J]. Aliment Pharmacol Ther, 2014, 40(3): 250-260. [3] Valle L, Vilar E, Tavtigian SV, et al. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine[J]. J Pathol, 2019, 247(5): 574-588. [4] Achike FI, To NP, Wang HD, et al. Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint[J]. Clin Exp Pharmacol Physiol, 2011, 38(1): 1-10. [5] Shen XD, Wang Y, Zhao R, et al. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis[J]. Int J Colorectal Dis, 2021, 36(10): 2215-2225. [6] Zhong L, Liu JF, Liu S, et al. Correlation between pancreatic cancer and metabolic syndrome: a systematic review and meta-analysis[J]. Front Endocrinol, 2023, 14: 1116582. doi: 10.3389/fendo.2023.1116582 [7] Zhan ZQ, Chen YZ, Huang ZM, et al. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study[J]. J Gastroenterol Hepatol, 2024, 39(4): 630-641. [8] Lin YL, Ness-Jensen E, Hveem K, et al. Metabolic syndrome and esophageal and gastric cancer[J]. Cancer Causes Control, 2015, 26(12): 1825-1834. [9] Emdin CA, Khera AV, Kathiresan S. Mendelian randomization[J]. Jama, 2017, 318(19): 1925-1926. [10] Li YJ, Li QX, Cao ZQ, et al. The causal association of polyunsaturated fatty acids with allergic disease: a two-sample Mendelian randomization study[J]. Front Nutr, 2022, 9: 962787. doi:10.3389/fnut.2022.962787 [11] Lind L. Genome-wide association study of the metabolic syndrome in UK biobank[J]. Metab Syndr Relat Disord, 2019, 17(10): 505-511. [12] Guerrero-Romero F, Rodríguez-Morán M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions[J]. Diabetes Care, 2005, 28(10): 2588-2589. [13] Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity[J]. Obes Rev, 2005, 6(4): 283-296. [14] Elsworth B, Mitchell R, Raistrick C A, et al. MRC-IEU UK Biobank gwas pipeline version 1[EB/OL].(2017-12-14)[2024-05-21]. https://data.bris.ac.uk/data/dataset/2fahpksont1zi26xosyamqo8rr [15] Manning AK, Hivert MF, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance[J]. Nat Genet, 2012, 44(6): 659-669. [16] Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels[J]. Nat Genet, 2013, 45(11): 1274-1283. [17] Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome[J]. eLife, 2018, 7: e34408. doi:10.7554/eLife.34408 [18] Burgess S, Davey SG, Davies NM, et al. Guidelines for performing mendelian randomization investigations: update for summer 2023[J]. Wellcome Open Res, 2023, 4: 186. doi:10.12688/wellcomeopenres.15555.3 [19] Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement[J]. JAMA, 2021, 326(16): 1614-1621. [20] Burgess S, Thompson SG, CHD Genetics Collaboration CRP. Avoiding bias from weak instruments in Mendelian randomization studies[J]. Int J Epidemiol, 2011, 40(3): 755-764. [21] de Klerk JA, Beulens JWJ, Mei HL, et al. Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study[J]. Diabetologia, 2023, 66(6): 1057-1070. [22] Agudo A, Bonet C, Travier N, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study[J]. J Clin Oncol, 2012, 30(36): 4550-4557. [23] Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study[J]. Lancet Oncol, 2021, 22(8): 1071-1080. [24] He SY, Xia CF, Li H, et al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors[J]. Sci China Life Sci, 2024, 67(1): 122-131. [25] Burgess S, Scott RA, Timpson NJ, et al. Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors[J]. Eur J Epidemiol, 2015, 30(7): 543-552. [26] Bowden J, Davey Smith G, Haycock PC, et al. Consis-tent estimation in mendelian randomization with some invalid instruments using a weighted median estimator[J]. Genet Epidemiol, 2016, 40(4): 304-314. [27] Bowden J, Hemani G, Davey Smith G. Invited commentary: detecting individual and global horizontal pleiotropy in mendelian randomization-a job for the humble heterogeneity statistic[J]. Am J Epidemiol, 2018, 187(12): 2681-2685. [28] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression[J]. Inter-national journal of epidemiology, 2015, 44(2): 512-525. [29] Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J]. Nat Genet, 2018, 50(5): 693-698. [30] Reynolds CJ, Fabiola Greco M, Allen RJ, et al. The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study[J]. Eur Respir J, 2023, 61(5): 2201585. [31] Yao F, Bo YC, Zhao LY, et al. Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017[J]. Nutrients, 2021, 13(12): 4475. doi: 10.3390/nu13124475 [32] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. Chinese Medical Association Diabetes Society. Reaction to guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(4):315-409. [33] Tahergorabi Z, Moodi M, Zardast M, et al. Metabolic syndrome and the risk of gastrointestinal cancer: a case-control study[J]. Asian Pac J Cancer Prev, 2018, 19(8): 2205-2210. [34] Mili N, Paschou SA, Goulis DG, et al. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations[J]. Endocrine, 2021, 74(3): 478-497. [35] 谢同辉, 陈志强, 赵丹文, 等. 代谢综合征与消化道癌症关系的研究进展[J]. 中国现代普通外科进展, 2022, 25(8): 633-635, 638. XIE Tonghui, CHEN Zhiqiang, ZHAO Danwen, et al. Research progress in metabolic syndrome and digestive tract cancer[J]. Chinese Journal of Current Advances in General Surgery, 2022, 25(8): 633-635, 638. [36] Belladelli F, Montorsi F, Martini A. Metabolic syndrome, obesity and cancer risk[J]. Curr Opin Urol, 2022, 32(6): 594-597. [37] Szablewski L. Changes in cells associated with insulin resistance[J]. Int J Mol Sci, 2024, 25(4): 2397. doi: 10.3390/ijms25042397 [38] 扈艳雯, 王志媛, 郁万江, 等. 52例肥胖患者脂肪分布与代谢综合征及糖代谢指标的相关性[J]. 山东大学学报(医学版), 2020, 58(8): 101-106. HU Yanwen, WANG Zhiyuan, YU Wanjiang, et al. Correlation of fat distribution with metabolic syndrome and glucose metabolism in 52 obese patients[J]. Journal of Shandong University(Health Sciences), 2020, 58(8): 101-106. [39] Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report[J]. CA Cancer J Clin, 2010, 60(4): 207-221. [40] Siegel AB, Zhu AX. Metabolic syndrome and hepatoce-llular carcinoma: two growing epidemics with a potential link[J]. Cancer, 2009, 115(24): 5651-5661. [41] Shi YW, Yang RX, Fan JG. Chronic hepatitis B infection with concomitant hepatic steatosis: current evidence and opinion[J]. World J Gastroenterol, 2021, 27(26): 3971-3983. [42] Selby LV, Ejaz A, Brethauer SA, et al. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery[J]. Expert Opin Investig Drugs, 2020, 29(2): 107-110. [43] Chettouh H, Lequoy M, Fartoux L, et al. Hyperinsu-linaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma[J]. Liver Int, 2015, 35(10): 2203-2217. [44] Polyzos SA, Chrysavgis L, Vachliotis ID, et al. Nonalcoholic fatty liver disease and hepatocellular carcinoma: Insights in epidemiology, pathogenesis, imaging, prevention and therapy[J]. Semin Cancer Biol, 2023, 93: 20-35. [45] Lee YB, Ha Y, Chon YE, et al. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B[J]. Clin Mol Hepatol, 2018, 25(1): 52-64. [46] Peleg N, Issachar A, Arbib OS, et al. Liver steatosis is a strong predictor of mortality and cancer in chronic he-patitis B regardless of viral load[J]. JHEP Reports, 2019, 1(1): 9-16. [47] Zhang JJ, Wu HD, Wang RY. Metabolic syndrome and esophageal cancer risk: a systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2021, 13(1): 8. doi: 10.1186/s13098-021-00627-6 [48] Rothwell JA, Jenab M, Karimi M, et al. Metabolic syndrome and risk of gastrointestinal cancers: an investigation using large-scale molecular data[J]. Clin Gastroenterol Hepatol, 2022, 20(6): e1338-e1352. [49] Lee JE, Han K, Yoo J, et al. Association between metabolic syndrome and risk of esophageal cancer: a nationwide population-based study[J]. Cancer Epidemiol Biomarkers Prev, 2022, 31(12): 2228-2236. [50] Du X, Hidayat K, Shi BM. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies[J]. Biosci Rep. 2017 May 11;37(3):BSR20160474. doi: 10.1042/BSR20160474 [51] 王罡强, 袁金秋, 张常华, 等. 代谢综合征及其组分与胃癌发生风险前瞻性队列研究[J]. 热带医学杂志, 2021, 21(9): 1096-1102. WANG Gangqiang, YUAN Jinqiu, ZHANG Changhua, et al. Associations of metabolic syndrome and its components with risk of gastric cancer: a prospective cohort study[J]. Journal of Tropical Medicine, 2021, 21(9): 1096-1102. [52] Sanikini H, Muller DC, Chadeau-Hyam M, et al. Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort[J]. PLoS One, 2020, 15(10): e0240413. doi:10.1371/journal.pone.0240413 [53] Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue[J]. Ann N Y Acad Sci, 2011, 1229: 45-52. doi:10.1111/j.1749-6632.2011.06096.x [54] van Kruijsdijk RCM, van der Wall E, Visseren FLJ. Obesity and cancer: the role of dysfunctional adipose tissue[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(10): 2569-2578. [55] Choi YJ, Lee DH, Han KD, et al. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer[J]. Eur J Epidemiol, 2018, 33(11): 1077-1085. [56] 杨刚, 张乐杨, 周雨迪, 等. 代谢综合征及其组份与结直肠癌根治术后短期预后的相关性[J]. 中国肿瘤临床, 2022, 49(19): 982-987. YANG Gang, ZHANG Leyang, ZHOU Yudi, et al. Relationship between metabolic syndrome and its components and short-term out-come after radical resection of colorectal cancer[J]. Chinese Journal of Clinical Oncology, 2022, 49(19): 982-987. [57] van Duijnhoven FJB, Bas Bueno-De-Mesquita H, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into cancer and nutrition[J]. Gut, 2011, 60(8): 1094-1102. [58] Ossoli A, Wolska A, Remaley AT, et al. High-density lipoproteins: a promising tool against cancer[J]. Biochim Biophys Acta BBA Mol Cell Biol Lipds, 2022, 1867(1): 159068. doi:10.1016/j.bbalip.2021.159068 [59] Zhao TJ, Zhu N, Shi YN, et al. Targeting HDL in tumor microenvironment: new hope for cancer therapy[J]. J Cell Physiol, 2021, 236(11): 7853-7873. |
| [1] | LI Jianfeng, ZHANG Zhan, DING Xinhua, GAO Fentang, HE Qinli, XIE Ping. Mendelian randomization analysis of dietary factors and cognitive impairment in European populations [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 36-43. |
| [2] | WANG Xiaolei, FANG Jun, WANG An, ZHU Wuhui, SHI Guangjun. Two-sample Mendelian randomization of the relationship between gut microbiota and the risk of extrahepatic cholangiocarcinoma [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 44-50. |
| [3] | YANG Hui, SU Shijing, LI Fen. Study on the causal relationship between cathepsins and risk of frailty based on bidirectional two-sample Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 67-76. |
| [4] | CHANG Yu, HU Yunfeng, WANG Huifeng, GUO Jing, ZHANG Tiao, HAO Yaqin, LIU Yu. A mendelian randomization study on the association between appendectomy and the risk of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 77-83. |
| [5] | YUAN Zonghuai, PAN Guangye, CHI Yuemei, AN Chuanguo, ZHANG Yonggang. Causal relationship between low grade serous ovarian cancer and breast cancer analyzed by Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 99-107. |
| [6] | ZHANG Zhan, LI Jianfeng, LI Yanling, WANG Bowen, ANGWEN Chenglinlongzhu, WANG Xin, ZHANG Xiaoming, XIE Ping. Mendelian randomization analysis of causality between dietary factors and preeclampsia [J]. Journal of Shandong University (Health Sciences), 2024, 62(8): 59-66. |
| [7] | FENG Yue, YU Yifan, WU Sijia, LI Hongkai, XUE Fuzhong. Mendelian randomization study of visceral adipose tissue and lung diseases [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 48-55. |
| [8] | WU Tong, YANG Jingyu, LIN Dang, XU Wanru, ZENG Yujun. Genetic association of lipids and lipid-lowering drugs with chronic obstructive pulmonary disease based on Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 54-63. |
| [9] | ZHAO Zhibo, MAN Zhentao, LI Wei. Role of cholesterol metabolism in osteoarthritis: a review of research progresses [J]. Journal of Shandong University (Health Sciences), 2024, 62(2): 1-9. |
| [10] | WU Fei, LI Qingli, XIAO Zhenwei. Causal association between cytokines and chronic kidney disease based on Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2024, 62(11): 85-95. |
| [11] | ZHANG Nana, ZHAO Yiming, LIU Xinmin. Causal relationship between uterine leiomyomas and breast cancer: a two-sample Mendelian randomization study [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 86-93. |
| [12] | ZHANG Tianxin, ZHANG Ting, HUANG Xin, HAN Jiayi, WANG Shukang. A mendelian randomization analysis on the causal associations between amino acids and type 2 diabetes [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 102-107. |
| [13] | CHANG Xin, LIU Shijia, HAN Lu. A Mendelian randomization study of aspirin use and the risk of endometrial cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 58-62. |
| [14] | ZHANG Kai, SI Shucheng, LI Jiqing, LIU Xiaowen, ZHAO Yingqi, XUE Fuzhong. Mendelian randomization study of sleep phenotypes and irritable bowel syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 109-114. |
| [15] | WU Xinying, FENG Yiping, CHANG Kaifeng, JIA Xianjie, XUE Fuzhong. Causal association between green space and cancer incidence [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 115-119. |
|
||